MSB 3.21% $1.13 mesoblast limited

Analysis of the EAP, page-434

  1. 2,126 Posts.
    lightbulb Created with Sketch. 1777
    "But you must be frustrated that you can't realise your vision as quickly as you'd like" I chuckled a bit at that!

    Don't think the speed of seeing our results predicates on the amount of funds we have! It's kinda like going to a feverish child, feeding him/her some panadol and saying, "GET BETTER NOW YOU CAN DO IT", we'll just have to patiently wait for the patients to react positively to our cells, let the docs/profs/nurses collect the data, let the prof and his merry crew of mend-its (haha couldn't resist it) analyse the data, submit it to the FDA and then ROLL OUT THE PDUFA.

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.